N Veulemans

Biography

Nancy Veulemans has over 25 years of experience in the pharmaceutical, healthcare and biotechnology industries and has more than 15 years of experience in tech-transfer of academic research to start-up companies. Starting in September 2016, Nancy was Senior Advisor Regulatory Affairs at Promethera and was appointed in February 2017 as VP Clinical and Medical Affairs where she is responsible for a successful implementation of the company’s clinical development plan. Nancy has broad expertise in regulatory and clinical affairs and has successfully led multiple clinical developments and market authorization applications of different compounds. In the past, Nancy worked at various biopharmaceutical companies such as Bristol Myers Squibb International, Pfizer and Charles River Laboratories. From 2000 to 2009 Nancy was VP Clinical and Regulatory Affairs at TiGenix where she brought a first-in-class, first cell-therapy product to Europe through full clinical development to the market. Nancy holds a Bachelor’s Degree of Science and obtained an honor’s degree in Biosciences Engineering at the Catholic University of Leuven. Nancy Veulemans has over 25 years of experience in the pharmaceutical, healthcare and biotechnology industries and has more than 15 years of experience in tech-transfer of academic research to start-up companies. Starting in September 2016, Nancy was Senior Advisor Regulatory Affairs at Promethera and was appointed in February 2017 as VP Clinical and Medical Affairs where she is responsible for a successful implementation of the company’s clinical development plan. Nancy has broad expertise in regulatory and clinical affairs and has successfully led multiple clinical developments and market authorization applications of different compounds. In the past, Nancy worked at various biopharmaceutical companies such as Bristol Myers Squibb International, Pfizer and Charles River Laboratories. From 2000 to 2009 Nancy was VP Clinical and Regulatory Affairs at TiGenix where she brought a first-in-class, first cell-therapy product to Europe through full clinical development to the market. Nancy holds a Bachelor’s Degree of Science and obtained an honor’s degree in Biosciences Engineering at the Catholic University of Leuven.

Research Interest

Biomedical Sciences